Pages that link to "Q57382081"
Jump to navigation
Jump to search
The following pages link to Adenovirus-Mediated Gene Transfer of Placental Growth Factor to Perivascular Tissue Induces Angiogenesis via Upregulation of the Expression of Endogenous Vascular Endothelial Growth Factor-A (Q57382081):
Displaying 25 items.
- Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels (Q24299513) (← links)
- Molecularly targeted drugs for metastatic colorectal cancer (Q26828735) (← links)
- Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy (Q26853604) (← links)
- Role of placenta growth factor in cancer and inflammation (Q33352793) (← links)
- Antiangiogenic gene therapy with soluble VEGFR-1, -2, and -3 reduces the growth of solid human ovarian carcinoma in mice (Q33713224) (← links)
- PlGF repairs myocardial ischemia through mechanisms of angiogenesis, cardioprotection and recruitment of myo-angiogenic competent marrow progenitors (Q34039453) (← links)
- Update on antiangiogenic therapy in colorectal cancer: aflibercept and regorafenib (Q34348270) (← links)
- VEGF is essential for hypoxia-inducible factor-mediated neovascularization but dispensable for endothelial sprouting (Q35164593) (← links)
- A computational analysis of in vivo VEGFR activation by multiple co-expressed ligands. (Q36314931) (← links)
- Current status of cardiovascular gene therapy (Q36823697) (← links)
- VEGF: an essential mediator of both angiogenesis and endochondral ossification (Q36949564) (← links)
- Gene therapy to prevent occlusion of venous bypass grafts (Q37176430) (← links)
- FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? (Q37333639) (← links)
- Pro- and anti-angiogenic therapy and atherosclerosis with special emphasis on vascular endothelial growth factors (Q37960607) (← links)
- Inhibition of placenta growth factor with TB-403: a novel antiangiogenic cancer therapy (Q38002923) (← links)
- HIF-mediated endothelial response during cancer progression. (Q38007880) (← links)
- PlGF: a multitasking cytokine with disease-restricted activity (Q38036234) (← links)
- Placental growth factor in cancer (Q38258289) (← links)
- Upregulation of hypoxia-inducible factor 1 alpha in local vein wall is associated with enhanced venous thrombus resolution. (Q38657877) (← links)
- Arsenite-mediated promotion of anchorage-independent growth of HaCaT cells through placental growth factor. (Q38930194) (← links)
- Neuropilin-2 and vascular endothelial growth factor receptor-3 are up-regulated in human vascular malformations (Q45427181) (← links)
- Therapeutic angiogenesis with placental growth factor improves exercise tolerance of ischaemic rabbit hindlimbs (Q45879204) (← links)
- KH902 suppresses high glucose-induced migration and sprouting of human retinal endothelial cells by blocking VEGF and PIGF. (Q46306730) (← links)
- Conbercept (KH-902) for the treatment of neovascular age-related macular degeneration. (Q53373714) (← links)
- Trends and Challenges in Tumor Anti-Angiogenic Therapies (Q90194802) (← links)